AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAR 4 - (NewsRx.com & NewsRx.net) -- House of Brussels Chocolates (HBSL), through its CEO Grant Petersen, announced several major corporate developments.
Firstly, HBSL has incorporated a subsidiary company, ChocoMed, Inc., to act as an umbrella company for HBSL's interest in investigating the use of chocolate as a carrier for dietary supplements, functional foods, and pharmaceutical compounds to treat various medical conditions.
Secondly, HBSL has added three new members to its medical advisory board, and William F. Donovan, MD, has been appointed to HBSL's board of directors.
Shortly after Brussels had announced its success in developing a perimenopausal, supplement-enriched bar for Culinova, Inc., HBSL approached Donovan, a substantial shareholder of the company, about forming a medical advisory board to seek out similar opportunities. The intention at that time was to simply have a board of top-notch medical professionals acting in an advisory capacity. Since then, Donovan reached out to several colleagues and quickly came to the conclusion that the opportunities for "marrying chocolate with medicine" were ...
Source: HighBeam Research, House of Brussels forms medical research subsidiary.